Skip to main content

How to Induce Arrhythmias with Caffeine?

  • Chapter
  • First Online:
Arrhythmia Induction in the EP Lab

Abstract

Caffeine is the most used stimulant for the central nervous system. It is a natural methylxanthine that is present in many beverages. In the USA 80% of adults use 3.5 cups of coffee/day on average the equivalent of 164 mg caffeine. Biological half-life of caffeine is 3–7 h in adults, with a plasma half-life of 3–5 h. The pharmacological effects of caffeine are similar to other methylxanthines that are found in chocolate or tea. Caffeine increases the action of norepinephrine in the human body and also augments the inotropic effects of other β -adrenergic drugs. It increases the heart rate, left ventricular output, and stroke output. The effects of caffeine range from a negative chronotropic and inotropic effect in case of a low dose to a positive chronotropic and inotropic effect in case of a high dose and atrial and ventricular arrhythmias in case of very high dose.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Raebel M, Black J. The caffeine controversy: what are the facts? Hosp Pharm. 1984;19:257–67.

    Google Scholar 

  2. Hodgamn MJ. Caffeine. In: Wexler P, editor. Encyclopedia of toxicology. San Diego: Academic Press; 1988. p. 209–10.

    Google Scholar 

  3. Bonati M, Latini R, Galleti F. Caffeine disposition after oral doses. Clin Pharmacol Therap. 1982;32:98–106.

    Article  CAS  Google Scholar 

  4. Liguori A, Hughes JR, Grass JA. Absorption and subjective effects of caffeine from coffee, cola and capsules. Pharmacol Biochem Behav. 1997;58:721–6.

    Article  CAS  Google Scholar 

  5. Stavric B. Methylxanthines: toxicity to humans. 2. Caffeine. Food Chem Toxicol. 1988;26:645–62.

    Article  CAS  Google Scholar 

  6. Watson J, Deary I, Kerr D. Central and peripheral effects of sustained caffeine use: tolerance is incomplete. Br J Clin Pharmacol. 2002;54:400–6.

    Article  CAS  Google Scholar 

  7. Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M. Effects of caffeine on human health. Food Addit Contam. 2003;20:1–30.

    Article  CAS  Google Scholar 

  8. Myers JP, Johnson DA, McVey DE. Caffeine and the modulation of brain function. In: Gupta BS, Gupta U, editors. Caffeine and behaviour: current views and research trends. Boca Raton: CRC Press; 1999. p. 17–30.

    Google Scholar 

  9. Daly JW, Shi D, Nikodyivic O, Jacobson KA. The role of adenosine receptors in the central action of caffeine. In: Gupta BS, Gupta U, editors. Caffeine and behaviour: current views and research trends. Boca Raton: CRC Press; 1999. p. 1–16.

    Google Scholar 

  10. Daly JW. In: Garattini S, editor. Caffeine, coffee, and health Mechanism of action of caffeine. New York: Raven Press; 1993. p. 97–150.

    Google Scholar 

  11. Nehlig A, Daval JL, Derby G. Caffeine and the central nervous system: mechanisms and action, biochemical, and psychostimulant effects. Brain Res Rev. 1992;17:139–70.

    Article  CAS  Google Scholar 

  12. Prineas R, Jacobs D, Crow R, Blackburn H. Coffee, tea and VPB. J Chronic Dis. 1980;33:67–72.

    Article  CAS  Google Scholar 

  13. Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest. 1981;67:1111–7.

    Google Scholar 

  14. Izzo JL, Ghosal A, Kwong T, Freeman RB, Jaenike JR. Age and prior caffeine use alter the cardiovascular and adrenomedullary responses to oral caffeine. Am J Cardiol. 1983;52:769–73.

    Article  CAS  Google Scholar 

  15. Forman J, Aizer A, Young CR. Myocardial infarction resulting from caffeine overdose in an anorectic woman. Ann Emerg Med. 1997;29:178–80.

    Article  CAS  Google Scholar 

  16. Bellet S, Horstmann E, Roman LR, DeGuzman NT, Kostis JB. Effect of caffeine on the ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Am Heart J. 1972;84:215–27.

    Article  CAS  Google Scholar 

  17. Ishida S, Ito M, Takahashi N, Fujino T, Akimitsu T, Saikawa T. Caffeine induces ventricular tachyarrhythmias possibly due to triggered activity in rabbits in vivo. Jpn Circ J. 1996;60:157–65.

    Article  CAS  Google Scholar 

  18. Mehta A, Jain AC, Mehta MC, Billie M. Caffeine and cardiac arrhythmias. An experimental study in dogs with review of literature. Acta Cardiol. 1997;52:273–83.

    CAS  PubMed  Google Scholar 

  19. Newcombe P, Renton K, Rautaharju P, Spencer A, Montague T. High-dose caffeine and cardiac rate and rhythm in normal subjects. Chest. 1988;94:90–4.

    Article  CAS  Google Scholar 

  20. Bioh G, Gallagher MM, Prasad U. Survival of a highly dose of caffeine. BMJ Case Rep. 2013. https://doi.org/10.1136/bcr-2012-007454.

  21. Chelsky LB, Cutler JE, Griffith K. Caffeine and ventricular arrhythmias. An electrophysiological approach. JAMA. 1990;264:2236–40.

    Article  CAS  Google Scholar 

  22. Sutherland D, McPherson D, Renton K, Spencer C, Montague T. The effects of caffeine on cardiac rate, rhythm, and ventricular repolarization. Chest. 1985;87:319–24.

    Article  CAS  Google Scholar 

  23. Harris A, Bluest R. Treatment of slow heart rate following acute myocardial infarction. Br Heart J. 1966;28:631–7.

    Article  CAS  Google Scholar 

  24. Dobmeyer D, Stine R, Leier C, Greenberg R, Schaal S. The arrhythmogenic effects of caffeine in human beings. N Engl J Med. 1983;308:814–6.

    Article  CAS  Google Scholar 

  25. Myers M, Harris L, Leenen F, Grant D. Caffeine as a possible cause of ventricular arrhythmias during the healing phase of acute myocardial infarction. Am J Cardiol. 1987;59:1024–8.

    Article  CAS  Google Scholar 

  26. Lemery R, Pecarskie A, Bernick J, Williams K, Wells G. A prospective controlled randomized study of caffeine in patients with supraventricular tachycardia undergoing electrophysiologic testing. J Cardiovasc Electrophysiol. 2015;26:1–6.

    Article  Google Scholar 

  27. Gould L, Reddy CV, Oh KC, Kim SG, Becker WH. Electrophysiologic properties of coffee in man. J Clin Pharmacol. 1979;19:46–55.

    Article  CAS  Google Scholar 

  28. Rashid A, Hines M, Scherlag BJ, Yamanashi WS, Lovallo W. The effects of caffeine on the inducibility of atrial fibrillation. J Electrocardiol. 2006;39:421–5.

    Article  Google Scholar 

  29. Di Rocco JR, During A, Morelli PJ, Heyden M, Biancaniello TA. Atrial fibrillation in healthy adolescents after highly caffeinated beverage consumption: two case reports. J Med Case Reports. 2011;5:18.

    Article  Google Scholar 

  30. Frost L, Vestergaard P. Caffeine and risk of atrial fibrillation or flutter: the Danish diet, cancer and health study. Am J Clin Nutr. 2005;81:578–82.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cecilia Lazea .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lazea, C. (2019). How to Induce Arrhythmias with Caffeine?. In: Cismaru, G. (eds) Arrhythmia Induction in the EP Lab. Springer, Cham. https://doi.org/10.1007/978-3-319-92729-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92729-9_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92728-2

  • Online ISBN: 978-3-319-92729-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics